Home › Entities › public_company › Plus Therapeutics

Plus Therapeutics

biopharmaceutical company
Organization public_company Q113510380
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 13 annual filings
Revenue
$5.21M
▼ 10.5% YoY FY2025
Net Income
-$22.39M
▼ 72.5% YoY FY2025
Assets
$16.32M
▲ 146.1% YoY FY2025
EPS (diluted)
$-0.29
▲ 87.6% YoY FY2025
$0.00$2.39M$4.79M$7.18M$9.58M FY2009: $5.84M · NI -$23.22M (-397.7% margin)FY2010: $8.25M · NI -$27.49M (-333.1% margin)FY2011: $7.98M · NI -$32.45M (-406.5% margin)FY2012: $8.71M · NI -$32.28M (-370.6% margin)FY2013: $7.12M · NI -$26.18M (-367.6% margin)FY2014: $4.95M · NI -$37.37M (-754.5% margin)FY2015: $4.84M · NI -$18.74M (-387.4% margin)FY2016: $4.66M · NI -$22.05M (-473.5% margin)FY2017: $2.69M · NI -$22.69M (-843.7% margin)FY2018: $3.67M · NI -$12.63M (-344.2% margin)FY2023: $4.91M · NI -$13.32M (-271.0% margin)FY2024: $5.82M · NI -$12.98M (-222.8% margin)FY2025: $5.21M · NI -$22.39M (-429.4% margin) '09'11'13'15'17'23'25
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession 0001193125-26-104258

Plus Therapeutics

Summary

Plus Therapeutics is a public company[1].

Key Facts

  • Plus Therapeutics's field of work was targeted therapy[2].
  • Plus Therapeutics's instance of is recorded as public company[3].
  • Plus Therapeutics's headquarters location is recorded as Austin[4].
  • Plus Therapeutics's stock exchange is recorded as Nasdaq[5].
  • +1996-00-00T00:00:00Z marks the founding of Plus Therapeutics[6].
  • Plus Therapeutics's official website is recorded as https://plustherapeutics.com/[7].
  • Plus Therapeutics's Crunchbase organization ID is recorded as cytori-therapeutics[8].
  • Plus Therapeutics's Central Index Key is recorded as 0001095981[9].

Body

Founding

+1996-00-00T00:00:00Z marks the founding of Plus Therapeutics[6].

Operations

Plus Therapeutics's headquarters location is recorded as Austin[4].

Industry

Plus Therapeutics's field of work was targeted therapy[2].

Ownership

Plus Therapeutics's stock exchange is recorded as Nasdaq[5].

Related Entities

Nasdaq public company

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [2] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Plus Therapeutics. Retrieved May 5, 2026, from https://4ort.xyz/entity/plus-therapeutics
MLA “Plus Therapeutics.” 4ort.xyz Knowledge Graph, 4ort.xyz, 5 May. 2026, https://4ort.xyz/entity/plus-therapeutics.
BibTeX @misc{4ortxyz_plus-therapeutics_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Plus Therapeutics}}, year = {2026}, url = {https://4ort.xyz/entity/plus-therapeutics}, note = {Accessed: 2026-05-05}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Plus Therapeutics — https://4ort.xyz/entity/plus-therapeutics (retrieved 2026-05-05)

Canonical URL: https://4ort.xyz/entity/plus-therapeutics · Last refreshed: